Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Performer
1650.3000 27.20 (1.68%)
NSE Jul 02, 2026 15:31 PM
Volume: 243.9K
 

1650.30
1.68%
Emkay
DLPL posted a robust quarter, with revenue growing 11% YoY on the back of
sample volume increasing 9% YoY and Swasthfit contributing 24% to the
topline.
Dr. Lal Pathlabs Ltd. has an average target of 1653.67 from 3 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended